BORGHESI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 12.527
AS - Asia 10.488
EU - Europa 8.579
AF - Africa 758
SA - Sud America 555
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 32.923
Nazione #
US - Stati Uniti d'America 12.361
VN - Vietnam 3.230
SG - Singapore 2.830
CN - Cina 2.486
GB - Regno Unito 2.425
IT - Italia 1.343
DE - Germania 1.257
SE - Svezia 804
HK - Hong Kong 672
FR - Francia 658
RU - Federazione Russa 534
IN - India 530
BR - Brasile 401
IE - Irlanda 334
NL - Olanda 281
TG - Togo 245
ZA - Sudafrica 232
EE - Estonia 197
UA - Ucraina 179
FI - Finlandia 152
JO - Giordania 122
CI - Costa d'Avorio 120
CA - Canada 110
JP - Giappone 108
NG - Nigeria 78
AR - Argentina 68
CH - Svizzera 67
BG - Bulgaria 66
BE - Belgio 62
BD - Bangladesh 58
PH - Filippine 55
TH - Thailandia 53
IR - Iran 49
IQ - Iraq 41
KR - Corea 41
ES - Italia 40
PL - Polonia 39
TW - Taiwan 36
AT - Austria 35
MX - Messico 34
ID - Indonesia 32
LT - Lituania 28
TR - Turchia 27
EC - Ecuador 21
PK - Pakistan 21
SC - Seychelles 20
CL - Cile 19
UZ - Uzbekistan 19
GR - Grecia 18
SA - Arabia Saudita 16
RO - Romania 15
VE - Venezuela 12
CO - Colombia 11
CZ - Repubblica Ceca 10
ET - Etiopia 10
MY - Malesia 10
AU - Australia 9
MA - Marocco 9
DO - Repubblica Dominicana 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
EG - Egitto 7
HR - Croazia 7
PS - Palestinian Territory 7
DK - Danimarca 6
KE - Kenya 6
LB - Libano 6
PE - Perù 6
UY - Uruguay 6
AZ - Azerbaigian 5
SN - Senegal 5
SY - Repubblica araba siriana 5
NO - Norvegia 4
NP - Nepal 4
OM - Oman 4
PT - Portogallo 4
TN - Tunisia 4
AL - Albania 3
BO - Bolivia 3
GH - Ghana 3
KG - Kirghizistan 3
KZ - Kazakistan 3
PA - Panama 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BF - Burkina Faso 2
BH - Bahrain 2
BZ - Belize 2
HN - Honduras 2
IL - Israele 2
LY - Libia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
AQ - Antartide 1
BB - Barbados 1
BY - Bielorussia 1
Totale 32.905
Città #
Southend 2.145
Singapore 1.877
Ashburn 1.474
Fairfield 1.139
Chandler 1.101
Houston 636
Hong Kong 635
Wilmington 581
Woodbridge 569
Seattle 564
San Jose 518
Dong Ket 500
Santa Clara 475
Ho Chi Minh City 470
Princeton 453
Cambridge 434
Hanoi 424
Ann Arbor 341
Dublin 330
Beijing 327
Lomé 245
Boardman 241
Nanjing 234
Lauterbourg 228
Westminster 223
Bologna 208
Padova 203
Berlin 189
Dallas 175
Jinan 150
Los Angeles 148
New York 146
Shenyang 130
Saint Petersburg 123
Helsinki 122
Amman 121
Abidjan 120
Dearborn 106
Medford 105
Bremen 98
Redondo Beach 97
Buffalo 96
Frankfurt am Main 92
Hebei 89
Milan 85
Changsha 84
Tokyo 83
Turin 81
Haiphong 78
Guangzhou 75
San Diego 74
Abeokuta 71
London 71
Munich 70
Nanchang 68
Da Nang 67
Tianjin 64
Sofia 60
Brussels 58
Florence 58
Toronto 57
Redwood City 52
São Paulo 52
Hangzhou 50
Zhengzhou 48
Jiaxing 45
Hefei 41
Düsseldorf 40
Yubileyny 40
Basingstoke 39
Haikou 39
Bern 37
Frattamaggiore 37
Falls Church 32
Ningbo 31
Phoenix 31
Jacksonville 30
Mountain View 30
Norwalk 29
Olalla 29
Taiyuan 29
Chicago 28
Falkenstein 28
Nuremberg 28
Shanghai 28
Taizhou 28
Fuzhou 27
Mülheim 27
Turku 27
Amsterdam 26
Biên Hòa 26
Orem 25
Redmond 25
Hải Dương 24
Rome 24
Leawood 23
Brooklyn 22
Lanzhou 22
Montreal 22
Warsaw 22
Totale 21.129
Nome #
3D reconstruction and physical renal model to improve percutaneous punture during PNL 432
Adverse Features and Competing Risk Mortality in Patients With High-Risk Prostate Cancer 283
Sex-related penile fracture with complete urethral rupture: A case report and review of the literature 252
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study. 251
ANALISI DELLE COMPLICANZE INTRAOPERATORIE E DELLE CONSEGUENZE SUL DECORSO POSTOPERATORIO DOPO NEFRECTOMIA PARZIALE. STUDIO PROSPETTICO MULTICENTRICO OSSERVAZIONALE RECORD1. 250
ACCURACY OF PET/CT WITH 11-C-CHOLINE IN THE RESTAGING OF RECURRENT PROSTATE CANCER PATIENTS WITH A SINGLE LESION AT BONE SCINTIGRAPHY 243
Accuracy of [11C] Choline positron emission tomography/computed tomography in preoperative staging in patients with bladder cancer referred to radical cistectomy: comparison with conventional computed tomography 237
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 231
Accuracy of 18f-facbc (anti1-amino-3-18f-fluorocyclobutane-1-carboxylic acid) in prostate cancer relapse: Results of a prospective trial 230
18F-FACBC Compared With 11C-Choline PET/CT in Patients With Biochemical Relapse After Radical Prostatectomy: A Prospective Study in 28 Patients. 224
Complications After Systematic, Random, and Image-guided Prostate Biopsy 224
Which patients with clinical localized renal mass would achieve the trifecta after partial nephrectomy? The impact of surgical technique 223
Can the multiphasic computed tomography (CT) scan be useful in the clinical management of small renal masses? 221
CHIRURGIA MININVASIVA PER IL TRATTAMENTO DELLA LITIASI DELL’ALTA VIA ESCRETRICE: RISULTATI PRELIMINARI DI CONFRONTO TRA TECNICA ROBOT-ASSISTITA E LAPAROSCOPICA 220
Prediction Nomogram for 68 Ga-PSMA-11 PET/CT in Different Clinical Settings of PSA Failure After Radical Treatment for Prostate Cancer 219
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel 215
An isolated penile mass in a young adult turned out to be a primary marginal zone lymphoma of the penis. A case report and a review of literature. 215
Active surveillance for clinically localized renal tumors: An updated review of current indications and clinical outcomes 214
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 210
18F-FACBC COMPARED WITH 11C-CHOLINE PET/CT IN PATIENTS WITH BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY: A PROSPECTIVE STUDY IN 79 PATIENTS 208
10 YEARS ONCOLOGIC OUTCOMES OF Robot-assISTED RADICAL PROSTATECTOMY: A PROPENSITY-SCORE MATCH ANALYSIS COMPARED WITH OPEN APPROACH 208
MRI DISPLAYS THE PROSTATIC CANCER ANATOMY AND IMPROVES THE BUNDLES MANAGEMENT BEFORE ROBOT ASSISTED RADICAL PROSTATECTOMY 208
Can testis-sparing surgery for small testicular masses be considered a valid alternative to radical orchiectomy? A prospective single-center study 206
18F-FACBC PET/CT FOR NODAL STAGING IN HIGH RISK PROSTATE CANCER: PRELIMINARY DIAGNOSTIC ACCURACY ANALYSIS 206
The prognostic impact of tumour size on cancer-specific and overall survival among patients with pathologic t3a renal cell carcinoma 206
68Ga-PSMA PET/CT for restaging prostate cancer after definitive therapy: Results of a prospective single-center trial 201
The impact of a structured intensive modular training in the learning curve of robot assisted radical prostatectomy. 199
Perioperative complications and mortality after radical cystectomy when using a standardized reporting methodology. 197
How does 68 Ga-prostate-specific membrane antigen positron emission tomography/computed tomography impact the management of patients with prostate cancer recurrence after surgery? 197
Holmium laser prostatectomy in a tertiary Italian center: A prospective cost analysis in comparison with bipolar TURP and open prostatectomy 197
Fibrotic Adhesive Toxic-fat (F.A.T.): the association of fibrotic and adhesive perirenal fat with peri-operative outcomes of robot-assisted par tial nephrectomy (RAPN) 196
ACCURATEZZA DELLA TC/PETCON 11-C-COLINA NELLA RISTADIAZIONE DEI PAZIENTI CON NEOPLASIA PROSTATICA RECIDIVA CON UNA SINGOLA LESIONE ALLA SCINTIGRAFIA OSSEA 196
Can the multiphasic computed tomography be useful in the clinical management of small renal masses? 193
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and midterm follow-up 193
SURVIVAL, CONTINENCE AND POTENCY (SCP) RECOVERY AFTER RADICAL RETROPUBIC PROSTATECTOMY: A LONG-TERM COMBINED EVALUATION OF SURGICAL OUTCOMES 192
"In-bore" MRI-guided Prostate Biopsy Using an Endorectal Nonmagnetic Device: A Prospective Study of 70 Consecutive Patients 192
The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high- risk prostate cancer 188
Three-dimensional digital reconstruction of renal model to guide preoperative planning of robot-assisted partial nephrectomy. 183
The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: looking for larger selection criteria for active surveillance candidates 182
TRIFECTA RATES IN A COHORT OF PATIENTS UNDERGOING OPEN, LAPAROSCOPIC AND ROBOT-ASSISTED PARTI AL NEPHRECTOMY FOR CLINICALLY LOCALIZED RENAL TUMORS AT LOW-INTERMEDIATE COMPLEXITY: A SINGLE-INSTITUTIONAL ANALYSIS 181
Compa rison of 18F-fluciclovine PET/CT with 11 C-Choline PET/CT for nodal staging in prostate cancer: a prospective study 181
18F-FACBC PET/CT in comparison to 11c-choline for the detection of prostate cancer relapse after radical prostatectomy: A perspective study in 50 patients 180
18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse A Comparison to 11C-Choline PET/CT 178
ANALISI DELLE COMPLICANZE POSTOPERATORIE E DEI FATTORI PREDITTIVI DOPO NEFRECTOMIA PARZIALE: STUDIO PROSPETTICO MULTICENTRICO OSSERVAZIONALE RECORD1 177
DUPLICE ENUCLEORESEZIONE RENALE ROBOTICA CON ACCESSO RETROPERITONEALE IN PAZIENTE CON PREGRESSA CHIRURGIA ADDOMINALE, TROMBOCITOPENIA CRONICA E CIRROSI EPATICA 177
La nefrolitotrissia percutanea Tubeless nel trattamento della litiasi renale: studio retrospettivo di confronto con la nefrolitrotrissia percutanea standard in una coorte di 317 pazienti 176
Detection of nodal micro metastases with serial section, immunohistochemistry and real time-polymerase chain reaction in intermediate and high risk prostate cancer patients submitted to radical prostatectomy with extended pelvic lymph node dissection: A perspective study 176
Detection of nodal micro metastases with serial section, immunohistochemistry and real time-polymerase chain reaction in intermediate and high risk prostate cancer patients submitted to radical prostatectomy with extended pelvic lymph node dissection: A perspective study 176
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor. 176
(68)Ga-PSMA-PET/CT-Guided Salvage Retroperitoneal Lymph Node Dissection for Disease Relapse After Radical Prostatectomy for Prostate Cancer 175
ACCURATEZZA DIAGNOSTICA DI 18F-FACBC PET/CT VS 11C-COLINA PET/CT NEI PAZIENTI CON RECIDIVA BIOCHIMICA DOPO TRATTAMENTO RADICALE PER CARCINOMA PROSTATICO: STUDIO PROSPETTICO SU 100 PAZIENTI. 175
Patterns of positive surgical margins after open radical prostatectomy and their association with clinical recurrence 175
The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer. 174
Nodal Occult Metastases in Intermediate- and High-Risk Prostate Cancer Patients Detected Using Serial Section, Immunohistochemistry, and Real-Time Reverse Transcriptase Polymerase Chain Reaction: Prospective Evaluation With Matched-Pair Analysis. 174
NEFRECTOMIA PARZIALE ROBOTICA CON APPROCCIO RETROPERITONEALE A QUATTRO BRACCIA 173
SOPRAVVIVENZA CANCRO SPECIFICA NEI PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE E MALATTIA AGGRESSIVA ALL’ESAME ISTOLOGICO DEFINITIVO. 172
Preservation of the Internal Vesical Sphincter and Proximal Urethra During Retropubic Radical Prostatectomy may Improve Earlier Recovery of Continence in Selected Patients 169
Comparative analysis of surgical margins status in patients who underwent radical retropubic prostatectomy or laparoscopic radical prostatectomy for prostate cancer: a large, single-institution experience 168
ElectRomagnetic synchronized real-time system for MRI-TRUS fusion targeted biopsy of prostate (Toshiba Aplio 500Tm) in a heterogeneous pa tients cohort: results and compa rison with systematic biopsy 168
Retroperitoneal approach for robot-assisted partial nephrectomy: technique and early outcomes 168
Molecular diagnostic tools for the detection of nodal micrometastases in prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection: a prospective study. 168
DETECTION OF NODAL MICRO-METASTASES WITH SERIAL SECTION, IMMUNOHISTOCHEMISTRY AND REAL TIME POLYMERASE CHAIN REACTION IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER PATIENTS SUBMITTED TO RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPH NODE DISSECTION: A PERSPECTIVE STUDY 168
Active surveillance for small renal masses diagnosed in elderly or comorbid patients: Looking for the best treatment strategy. 168
Differing Risk of Cancer Death Among Patients With Pathologic T3a Renal Cell Carcinoma: Identification of Risk Categories According to Fat Infiltration and Renal Vein Thrombosis. 167
PREOPERATIVE MULTI PARAMETRIC MAGNETIC RESONANCE IMAGING AND NEUROVASCULAR BUNDLE MANAGEMENT: SURGICAL PLAN CHANGE IN COURSE OF Robot-assISTED RADICAL PROSTATECTOMY 167
Patterns of positive surgical margins after surgery in prostate cancer pa tients and their association with clinical recurrence 167
PADUA and R.E.N.A.L. nephrometry scores correlate with perioperative outcomes of robot-assisted partial nephrectomy: analysis of the Vattikuti Global Quality Initiative in Robotic Urologic Surgery (GQI-RUS) database 167
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer. 167
Radiological evaluation by magnetic resonance of the ‘new anatomy’ of transsexual patients undergoing male to female sex reassignment surgery 165
VALUTAZIONE DELLA CONTINENZA URINARIA DOPO PROSTATECTOMIA RADICALE IN PAZIENTI SOTTOPOSTI A RIABILITAZIONE POST OPERATORIA DEL PAVIMENTO PELVICO: RISULTATI A CONFRONTO FRA TECNICA LAPAROTOMICA E LAPAROSCOPICA 163
POSSIAMO INCLUDERE NELLA SORVEGLIANZA ATTIVA PER NEOPLASIA PROSTATICA, PAZIENTI CON CGS 3+4 IN UN UNICO PRELIEVO BIOPTICO? RISULTATI A MEDIO TERMINE DI UN SINGOLO CENTRO DOPO REVISIONE ISTOLOGICA SISTEMATICA DEI PRELIEVI BIOPTICI E DEI REPERTI OPERATORI 163
TESTIS SPARING SURGERY FOR SMALL TESTICULAR MASSES: SINGLE CENTER RETROSPECTIVE ANALYSIS 163
SURVIVAL, CONTINENCE AND POTENCY (SCP) RECOVERY AFTER RADICAL RETROPUBIC PROSTATECTOMY: A LONG-TERM COMBINED EVALUATION OF SURGICAL OUTCOMES 162
18F-FACBC PET/CT VS. 11C-CHOLINE FOR THE DETECTION OF PROSTATE CANCER RELAPSE AFTER RADICAL TREATMENT 162
THE VALUE OF HISTOLOGICAL REVISION OF BIOPSY CORES IN PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE: COMPARISON WITH SURGICAL SPECIMENS AFTER RADICAL PROSTATECTOMY AND CLINICAL FOLLOW-UP 162
Posterior muscle-fascial reconstruction and knotless urethro-neo bladder anastomosis during robot-assisted radical cystectomy: Description of the technique and its impact on urinary continence. 162
Retroperitoneal Robot-Assisted Versus Open Partial Nephrectomy for cT1 Renal Tumors: A Matched-Pair Comparison of Perioperative and Early Oncological Outcomes. 161
Preoperative Staging With 11C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate Cancer. 161
Prognostic significance of positive surgical margins after radical prostatectomy for prostate cancer 160
DIAGNOSTIC ACCURACY OF 11C-CHOLINE PET/CT IN COMPARISON WITH CONTRASTENHANCED CT IN THE PREOPERATIVE LYMPH-NODE STAGING OF BLADDER CANCER USING THE PATHOLOGICAL SPECIMENS AS REFERENCE STANDARD 160
Survival, continence and potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes 160
MODULAR TRAINING BEFORE ROBOT-ASSISTED RADICAL PROSTATECTOMY: RISULTATI OF A SINGLE SURGEON'S EXPERIENCE 159
Small Renal Masses Managed With Active Surveillance: Predictors of Tumor Growth Rate After Long-Term Follow-Up. 159
Survival, Continence and Potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes. 158
Role of testis sparing surgery in the conservative management of small testicular masses: oncological and functional perspectives. 157
QUAL'È L' IMPATTO DELL'ESTENSIONE DELLA LINFECTOMIA PELVICA ESEGUITA IN CORSO DI PROSTATECTOMIA RADICALE PER CARCINOMA PROSTATICO SULLA RIPRESA BIOCHIMICA NEI PAZIENTI PTXN0? 157
MULTIPLA NEFRECTOMIA PARZIALE ROBOTICA "CLAMPLESS", CON L'AUSILIO DI ECOGRAFIA INTRAOPERATORIA (TILEPRO®) IN PAZIENTE MONORENE CHIRURGICO 157
Laparoscopic radical prostatectomy: 10 years of experience at a single institution. 157
POSITRON-EMISSION TOMOGRAPHY IN IMAGING AND STAGING PROSTATE CANCER 156
IMPATTO ECONOMICO DELLA TERAPIA CHIRURGICA A CIELO APERTO ED ENDOSCOPICA PER L’IPERTROFIA PROSTATICA BENIGNA: ANALISI E CONFRONTO DEI COSTI SOSTENUTI NEL 2015 DA UN CENTRO DI TERZO LIVELLO 156
The Prognostic Impact of Tumor Size on Cancer-Specific and Overall Survival Among Patients With Pathologic T3a Renal Cell Carcinoma 156
LYMPH NODE DENSITY IN NODE-POSITIVE PATIENTS TREATED WITH RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 155
PERIOPERATIVE RESULTS , EARLY ONCOLOGICAL OUTCOMES AND TRIFECTA RATE IN PATIENTS UNDERGOING OPEN, LAPAROSCOPIC AND ROBOT-ASSISTED PARTI AL NEPHRECTOMY FOR CLINICALLY LOCALIZED RENAL TUMORS: A SINGLE INSTITUTIONAL ANALYSIS 155
DIAGNOSTIC ACCURACY OF 11C-CHOLINE PET/CT COMPARED TO CONTRASTENHANCED CT IN THE POSTOPERATIVE RESTAGING OF RECURRENT BLADDER CANCER: ANALYSIS OF 20 CONSECUTIVE PATIENTS 154
MAGNETIC RESONANCE/ULTR ASOUND-GUIDED FUSION PROSTATE BIOPSY: CANCER DETECTION RATE WITHIN CONSECUTIVE CORES TAKEN 154
PROGNOSTIC SIGNIFICANCE OF POSITIVE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER 153
PREDICTING CANCER- SPECIFIC AND OTHER-CAUSE MORTALITY IN ELDERLY PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER: A COMPETING RISK ANALYSIS 153
Can side-specific biopsy findings predict the side of nodal metastasis in clinically localized prostate cancer? Results from a multicenter prospective survey 152
LAPAROSCOPIC AND ROBOTIC URETERAL STENOSIS REPAIR: A MULTI-INSTITUTIONAL EXPERIENCE WITH A LONG-TERM FOLLOW UP 152
State of the art of PET/CT with 11-choline and 18F-fluorocholine in the diagnosis and follow-up of localized and locally advanced prostate cancer 151
Totale 18.605
Categoria #
all - tutte 83.487
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.487


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.307 0 0 0 0 0 0 0 0 0 107 80 1.120
2021/20224.152 809 137 203 235 407 222 63 249 145 230 794 658
2022/20234.428 434 811 254 603 263 298 128 233 791 188 302 123
2023/20241.106 109 197 38 120 94 221 71 74 24 83 27 48
2024/20254.326 167 721 366 355 701 279 265 120 28 347 117 860
2025/20268.833 794 576 918 567 1.204 546 942 316 2.156 814 0 0
Totale 33.579